Search alternatives:
wt decrease » _ decrease (Expand Search), awd decreased (Expand Search), step decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
wt decrease » _ decrease (Expand Search), awd decreased (Expand Search), step decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
-
8681
-
8682
-
8683
-
8684
<i>chb-3</i> encodes a novel protein with a zf-MYND motif.
Published 2010“…Y50C1, Y2F4 (<i>C. elegans</i> genomic YAC clone), and a Y48G1A.3 PCR fragment (6.5 kb) which contained the Y48G1A.3 predicted gene and 1 kb of upstream sequence, rescued the Daf-c phenotype of <i>chb-3(eg52)</i>. …”
-
8685
-
8686
-
8687
-
8688
-
8689
-
8690
-
8691
-
8692
-
8693
Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers
Published 2019“…Furthermore, the experiments revealed that the retinoid-sensitive cell lines showed a uniform pattern of change after treatment with both natural and sensitive retinoids: increased DDX39A and decreased PBX1 protein levels. …”
-
8694
-
8695
-
8696
-
8697
-
8698
RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity
Published 2015“…AIMs also directly inhibit tumor cell growth by modulating oncogenic signaling pathways, such as IKKβ/NF-κB. Here, we characterized the in vitro antioxidant, anti-inflammatory, and anticancer activities of RTA 408, a novel AIM that is currently being evaluated in patients with advanced malignancies. …”
-
8699
-
8700